Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
P/S ratio for Heron Therapeutics (HRTX)
P/S ratio as of April 2024 (TTM): 2.90
According to Heron Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.89904. At the end of 2023 the company had a P/S ratio of 2.01.
P/S ratio history for Heron Therapeutics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.01 | -27.25% |
| 2022 | 2.76 | -74.39% |
| 2021 | 10.8 | -50.56% |
| 2020 | 21.8 | 49.97% |
| 2019 | 14.5 | -44.46% |
| 2018 | 26.2 | -30.68% |
| 2017 | 37.8 | -90.59% |
| 2016 | 401 | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | -100% |
| 2011 | 71.2 | 411.52% |
| 2010 | 13.9 | -65.11% |
| 2009 | 39.9 | 13.61% |
| 2008 | 35.1 | 34.06% |
| 2007 | 26.2 | |
| 2005 | 7.17 | -6.14% |
| 2004 | 7.64 | -26.71% |
| 2003 | 10.4 | 181.79% |
| 2002 | 3.70 | -71.51% |
| 2001 | 13.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | 2.70 | -7.01% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | 1.81 | -37.40% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 9.52 | 228.21% | 🇺🇸 USA |
 Alkermes ALKS | 2.51 | -13.41% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | 2.69 | -7.23% | 🇺🇸 USA |